And we look forward to the additional studies that will come out with Tirzepatide, particularly in knowing its potential benefit with cardiovascular endpoints.
Clinical data from STEP and SURMOUNT trials show tirzepatide users achieved approximately 20-22% weight loss at highest doses, compared to semaglutide's 15-17% at comparable timepoints
"Adverse effects of GLP-1 receptor agonists." The review of diabetic studies: RDS 11.3 (2015): 202.
Once you start your medication, you will be seen in our clinic every month or sooner if needed to evaluate your progress
This face cream is typically gentle enough to be used on various skin types, including normal, dry, and combination skin
Example: an unopened injection that partly froze in a travel fridge needs different follow-up than one kept at stable room temperature during a day indoors